Unfolding Neurological and Neuropsychiatric
Complications due to Covid-19

Institute for Molecular Medicine Finland

FIMM – Institute for Molecular Medicine Finland is a translational research institute focusing on human genomics and precision medicine as part of the Helsinki Institute of Life Science HiLIFE at the University of Helsinki.

Role within NeuroCOV

FIMM is responsible for epidemiological characterization of NeuroCOVID including the identification of neurological conditions emerging in COVID-19 patients and their prevalence rates. In particular, together with the University of Umeå, FIMM will form nation-wide register-based cohorts to investigate neurological consequences in COVID-19 patients and in the offspring of mothers that were tested COVID-19 positive. Furthermore, we will take part in developing individual prediction models for NeuroCOVID risk by combining clinical and genetic data.

Main contacts

Photo of Andrea Ganna, PhD
Andrea Ganna, PhD

Group Leader

Photo of Anna-Leena Vuorinen, PhD
Anna-Leena Vuorinen, PhD

Senior Scientist